TELA Bio, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.76
- 52-Week Range
- $0.50 – $1.50
- Market Cap
- $35.25M
- P/E (TTM)
- —
- EPS (TTM)
- -0.74
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- —
- PEG Ratio
- —
- Return on Equity
- —
- Return on Assets
- -35.59%
- Gross Margin
- 67.67%
- Operating Margin
- -40.46%
- Profit Margin
- -53.57%
- Current Ratio
- 0.61
- Debt/Equity
- —
- Total Debt
- $58.04M
- Free Cash Flow
- $-17.08M
- Revenue Growth
- -8.40%
- Earnings Growth
- —
- Enterprise Value
- $70.63M
Market Snapshot
About
TELA Bio, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials for soft tissue reconstruction. The company manufactures OviTex, a portfolio of advanced reinforced tissue matrices that improve clinical outcomes in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. TELA uses ovine rumen as a biomaterial scaffold.